BridgeMD
New treatment option for Stroke
Official title Telerehabilitation Robotics for Upper Limb Rehabilitation After STroke
ClinicalTrials.gov ID: NCT06270459
What this study is testing
- What it's testing
- There has been an observed decrease in motor and functional ability and non-use of the impaired limb in chronic patients. This is due to the immediate drop in intensive daily therapy (5 days per week for 3 hours/day) that is usually provided during the inpatient (acute) phase upon discharge from the hospital.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 90
You may be able to join if
- Clinical stroke (ischaemic or haemorrhagic) confirmed by admitting doctors and CT, CT angiography or MRI brain imaging.
- Age 21 to 90 years, both males and females.
- At least \> 28 days post stroke.
- Upper limb motor impairment of Fugl-Myer Motor Assessment (FMA) scale 10 to 60
- Has a stable home abode and a carer/ NOK to supervise home based exercise.
You likely can't join if
- Non-stroke related causes of arm motor impairment.
- Medical conditions incompatible with research participation: uncontrolled medical illnesses (hypertension or diabetes, ischaemic heart disease...
- Anticipated life expectancy of \< 6 months.
- Inability to tolerate sitting continuously for 60 minutes.
- Local factors potentially worsened by intensive robot-aided arm therapy and computer-based training: active seizures within 3 months, spasticity of...
- Hemianesthesia of affected limb.
See the full eligibility criteria
- Clinical stroke (ischaemic or haemorrhagic) confirmed by admitting doctors and CT, CT angiography or MRI brain imaging.
- Age 21 to 90 years, both males and females.
- At least \> 28 days post stroke.
- Upper limb motor impairment of Fugl-Myer Motor Assessment (FMA) scale 10 to 60
- Has a stable home abode and a carer/ NOK to supervise home based exercise.
- Ability to sit supported continuously for 60 minutes.
- Montreal Cognitive Assessment (MOCA) score \> 21/30
- Able to understand purpose of research and give consent.
- Non-stroke related causes of arm motor impairment.
- Medical conditions incompatible with research participation: uncontrolled medical illnesses (hypertension or diabetes, ischaemic heart disease, congestive heart failure, bronchial asthma, end stage...
- Anticipated life expectancy of \< 6 months.
- Inability to tolerate sitting continuously for 60 minutes.
- Local factors potentially worsened by intensive robot-aided arm therapy and computer-based training: active seizures within 3 months, spasticity of Modified Ashworth Scale grades \>2 skin wounds, shoulder, arm pain VAS...
- Hemianesthesia of affected limb.
- History of dementia, severe depression, agitation, or behavioural problems.
- Pregnancy or lactation in females
- Absence of reliable carer to provide supervision during home training
The study team makes the final eligibility decision.
Where it's taking place
- Singapore, Singapore, Singapore
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Singapore, Singapore, Singapore. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.